Metabolite

KNApSAcK Entry

id C00030400
Name Ginsenoside Rg3
CAS RN 14197-60-5
Standard InChI InChI=1S/C42H72O13/c1-21(2)10-9-14-42(8,51)22-11-16-41(7)29(22)23(45)18-27-39(5)15-13-28(38(3,4)26(39)12-17-40(27,41)6)54-37-35(33(49)31(47)25(20-44)53-37)55-36-34(50)32(48)30(46)24(19-43)52-36/h10,22-37,43-51H,9,11-20H2,1-8H3/t22-,23+,24+,25+,26-,27+,28-,29-,30+,31+,32-,33-,34+,35+,36-,37-,39-,40+,41+,42-/m0/s1
Standard InChI (Main Layer) InChI=1S/C42H72O13/c1-21(2)10-9-14-42(8,51)22-11-16-41(7)29(22)23(45)18-27-39(5)15-13-28(38(3,4)26(39)12-17-40(27,41)6)54-37-35(33(49)31(47)25(20-44)53-37)55-36-34(50)32(48)30(46)24(19-43)52-36/h10,22-37,43-51H,9,11-20H2,1-8H3

Cluster

Phytochemical cluster No. 51
KCF-S cluster No. 32

Link

ChEMBL

By standard InChI CHEMBL398412
By standard InChI Main Layer CHEMBL398412 CHEMBL1095008 CHEMBL1735785 CHEMBL2151041

KEGG

By LinkDB

CTD

By CAS RN C097367

Species

Summary

Plant class

class name count
asterids 2

Family

family name count
Araliaceae 2

List (2)

* NCBI
KNApSAcK organism *ID *family *plant class *kingdom
Panax ginseng C.A.Meyer 4053 Araliaceae asterids Viridiplantae
Panax notoginseng 44586 Araliaceae asterids Viridiplantae

Human Protein / Gene in interaction

2 ChEMBL Protein in interactions

accession description class description compound assay ID (# of activities) # of diseases
(OMIM / KEGG)
P11387 DNA topoisomerase 1 Isomerase CHEMBL398412 CHEMBL1095008 CHEMBL1111926 (2)
0 / 0
P11388 DNA topoisomerase 2-alpha Isomerase CHEMBL398412 CHEMBL1095008 CHEMBL1111927 (2)
0 / 0

CTD interaction (8)

compound gene gene name gene description interaction interaction type form reference
pmid
C097367 367 AR
AIS
DHTR
HUMARA
HYSP1
KD
NR3C4
SBMA
SMAX1
TFM
androgen receptor ginsenoside Rg3 inhibits the reaction [Testosterone results in increased expression of AR protein] decreases reaction
/ increases expression
protein 22101440
C097367 367 AR
AIS
DHTR
HUMARA
HYSP1
KD
NR3C4
SBMA
SMAX1
TFM
androgen receptor ginsenoside Rg3 results in increased degradation of AR protein increases degradation
protein 22101440
C097367 332 BIRC5
API4
EPR-1
baculoviral IAP repeat containing 5 ginsenoside Rg3 results in decreased expression of BIRC5 mRNA decreases expression
mRNA 19778801
C097367 332 BIRC5
API4
EPR-1
baculoviral IAP repeat containing 5 ginsenoside Rg3 results in decreased expression of BIRC5 protein decreases expression
protein 19778801
C097367 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) ginsenoside Rg3 results in increased cleavage of CASP3 protein increases cleavage
protein 22101440
C097367 354 KLK3
APS
KLK2A1
PSA
hK3
kallikrein-related peptidase 3 (EC:3.4.21.77) ginsenoside Rg3 inhibits the reaction [Testosterone results in increased expression of KLK3 mRNA] decreases reaction
/ increases expression
mRNA 22101440
C097367 354 KLK3
APS
KLK2A1
PSA
hK3
kallikrein-related peptidase 3 (EC:3.4.21.77) ginsenoside Rg3 inhibits the reaction [Testosterone results in increased expression of KLK3 protein] decreases reaction
/ increases expression
protein 22101440
C097367 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) ginsenoside Rg3 results in increased cleavage of PARP1 protein increases cleavage
protein 22101440

Related Disease

Diseases related to CTD interactions

2 disease from interactions of metabolites

MeSH disease OMIM compound disease name evidence type reference
pmid
D000647 C097367 Amnesia therapeutic
15832823
D018827 C097367 Carcinoma, Lewis Lung therapeutic
16152834